Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
15.65% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
AMRN · Jun 30, 2026
AMARIN CORP PLC\UK. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001193125-26-323845General Corporate
Evidence method
Yoy · gp.fundamentals.revenue
-41.97% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
388.70% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
35.51% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-28.45% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.31% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.97% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/6 normalizedLevel 3Dec 31, 20230/6 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/7 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 14.15%
- Current
- 15.65%
- Delta
- 1.49%
- Previous
- 7.41%
- Current
- -41.97%
- Delta
- -49.38%
- Previous
- 406.77%
- Current
- 388.70%
- Delta
- -18.08%
- Previous
- 39.37%
- Current
- 35.51%
- Delta
- -3.86%
- Previous
- -25.11%
- Current
- -28.45%
- Delta
- -3.34%
- Previous
- 10.34%
- Current
- 11.31%
- Delta
- 0.97%
- Previous
- 5.16%
- Current
- 4.97%
- Delta
- -0.19%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Transitioned To · AMRN Fundamental State →Transitioned To · AMRN CASH_GENERATION_INCREASED →Transitioned To · AMRN GROWTH_DECREASED →Transitioned To · AMRN INVENTORY_PRESSURE_DECREASED →Transitioned To · AMRN MARGIN_DECREASED →Transitioned To · AMRN PROFITABILITY_DECREASED →Transitioned To · AMRN R_AND_D_INTENSITY_INCREASED →Transitioned To · AMRN SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.